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ABSTRACT; 
Background; Psoriasis is a common chronic recurrent inflammatory skin disease and platelet activation has 
been reported to be associated with its pathogenesis. This study was done to document mean MPV levels in 
patients with psoriasis vulgaris in our population as local data is scarce on this topic. Objectives; To determine 
MPV in patients with psoriasis vulgaris and to compare MPV in psoriasis with PASI > 10 and PASI < 10. 
Material and Methods; Patients fulfilling the stated criteria were recruited through Dermatology OPD of 
Nishtar Hospital, Multan, Pakistan. Purpose of the study was explained to them and informed consent was signed 
before their enrolment into the study. Relevant history, physical examination, PASI, and BMI was carried out. 
Laboratory parameters included CBC (hemoglobin, White blood cell, platelet count, MPV, PDW) and was 
measured using an auto-analyzer (Sysmex XE 2000 Germany). Alanine aminotransferase(ALT), Blood urea 
nitrogen(BUN), Creatinine, plasma sugar levels, Uric acid, Serum cholesterol, ESR, Hepatitis B and C screening 
and a baseline ECG was performed. Data was entered and analyzed by software SPSS version 15. Results; Our 
study comprised of a total of 100 patients meeting inclusion criteria of our study. Of these 100 study cases, 66 
(66%) were male patients while 34 (34 %) were female patients. Mean age of our study cases was 39.98 ± 9.66 
years (with minimum age of our study cases was 26 years while maximum age was 60 years). Of these 100 study 
cases, 41 (41 %) belonged to rural areas and 59 (59 %) belonged to urban areas. Monthly family income up to 
Rs. 50000 was noted in 48 (48%) while more than 50000 rupees was noted in 52 (52 %) of our study cases. 
Mean body mass index of our study cases was 23.62 ± 2.18 kg/m2 and BMI more than 25 kg/m2 was noted in 18 
(18 %) of our study cases. Of these 100 study cases, 78 (78%) had PASI less than 10 while 22 (22%) had PASI 
equal /more than 10. Mean MPV was 8.63 ±  0.67 fL (with minimum MPV was 7.8 fL while maximum was 9.9 
fL). Conclusion; Mean platelet volume (MPV) was elevated among patients having psoriasis vulgaris and was 
significantly increased in patients with PASI ≥ 10 or disease severity. MPV is a good marker for disease severity 
of psoriasis vulgaris. MPV was significantly associated with gender, age, socioeconomic status, BMI and disease 
severity. All the clinicians treating such patients should regularly monitor MPV levels for early diagnosis of 
severity of the disease for better clinical outcomes.  
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INTRODUCTION 
Psoriasis is a prevalent, chronic inflammatory skin disease that affects approximately 0.5%–1% of children and 
2%–3% of the world’s population.1 Its most common clinical variant is termed as psoriasis vulgaris, which 
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affects approximately 85 to 90% of all patients with the disease.
 
Psoriasis Vulgaris is characterized by oval or 
irregularly shaped, red, sharply demarcated, raised plaques covered by silvery scales. The disease is defined by a 
series of linked cellular changes in the skin: Hyperplasia of epidermal keratinocytes, vascular dilatation, and 
infiltration of various types of leucocytes in affected skin.
2
It is believed to be multifactorial with numerous key 
components including genetic susceptibility, environmental triggers in combination with skin barrier disruption 
and immune dysfunction.
3
 It is mediated by crosstalk between epidermal keratinocytes, dermal vascular cells, 
and immunocytes such as antigen presenting cells (APCs),macrophages , langherhan ’s cells ,natural killer cells 
and T cells.1 Platelets are closely linked to the pathogenesis of inflammatory skin diseases, including psoriasis, 
atopic dermatitis, contact dermatitis, and urticaria via various mechanisms. Platelet aggregation is greatly 
enhanced in psoriatic patients compared with that in healthy individuals, and this elevated aggregation is 
markedly decreased after improvement of psoriatic skin lesions 4 With both surface receptors (P-selectin, 
integrin’s, CD40, Toll-like receptors and chemokine receptors) and stored mediators (adenosine diphosphate, 
adenosine triphosphate, serotonin, cytokines, and chemokines), they are able to respond to various stimuli to 
activate inflammatory responses.
5 
Among the wide array of methods measuring platelet activation, mean platelet volume (MPV) is a simple 
parameter to estimate platelet activity and aggregation.6It is measured by automated hematology analyzer and is 
included in routine complete blood count (CBC) analysis. There are various reports regarding MPV in psoriasis, 
with conflicting and supportive results. Dae Suk Kim et al 
7 
reported 9.862 + 0.75 in psoriasis patients with 
PASI<10, and 10.08 + 0.67 in psoriasis patients with PASI>10 with p value of 0.038. The change of MPV was 
closely related to the clinical severity.  
Zaheer et al 
8 
reported that MPV was found higher in the patients of psoriasis as compared to the healthy 
individuals. The mean value of MPV in case group was 8.24 ± 1.22 fl, whereas in the control group was 7.29 ± 
0.77 fl (p<0.05). 
However Saleh et al9 showed no difference of MPV between psoriasis and controls with MPV values of 9.32 ± 
1.30 fl with a p value of 0.55. 
Based upon the contrary studies mentioned above, this study is proposed to study the relationship between MPV 
and psoriasis. Besides this psoriasis is fairly common ailment in Pakistan and there is quite dearth of data in 
literature regarding MPV and its relationship with disease severity 
10, 11
, it will provide necessary data for the 
further scholars to build on.  
 
MATERIAL AND METHODS 
A total of 100 Patients with psoriasis vulgaris on history and examination aged more than 18 years of either sex 
were included in this descriptive cross-sectional study. Patients with hypertension, diabetes, cardiovascular 
disorders, obesity, cancer, hematological disorders, rheumatoid arthritis, inflammatory bowel disease, chronic 
liver disease, chronic kidney disease, autoimmune disorders and patients on medication which affects platelet 
functions (e.g. acetyl salicylates, anti-epileptics, heparin) were excluded from our study. Patients fulfilling the 
stated criteria were recruited through Dermatology OPD of Nishtar Hospital, Multan, Pakistan. Purpose of the 
study was explained to them and informed consent was signed before their enrolment into the study. Relevant 
history, physical examination, PASI, and BMI was carried out. Laboratory parameters included CBC 
(hemoglobin, White blood cell, platelet count, MPV, PDW) and was measured using an auto-analyzer (Sysmex 
XE 2000 Germany). Alanine aminotransferase(ALT), Blood urea nitrogen(BUN), Creatinine, plasma sugar 
levels, Uric acid, Serum cholesterol, ESR, Hepatitis B and C screening and a baseline ECG was performed. Data 
was entered and analyzed by software SPSS version 15. Descriptive statistics was calculated for quantitative 
variables like age, MPV and BMI and presented as mean + SD. Frequencies and percentages were calculated for 
gender, obesity, residential status, monthly family income and disease severity. Independent sample t-test was 
used to compare the MPV between PASI ≥ 10 and PASI < 10. P value of < 0.05 was considered significant. 
 
RESULTS; 
Our study comprised of a total of 100 patients meeting inclusion criteria of our study. Of these 100 study cases, 
66 (66%) were male patients while 34 (34 %) were female patients. Mean age of our study cases was 39.98 ± 
9.66 years (with minimum age of our study cases was 26 years while maximum age was 60 years). Mean age of 
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the male patients was noted to be 41.77 ± 10.82 years while that female patients was 36.50 ± 5.50 years 
(p=0.009). Our study results have indicated that majority of our study cases i.e. 60 (60%) were aged up to 40 
years. Of these 100 study cases, 41 (41 %) belonged to rural areas and 59 (59 %) belonged to urban areas. 
Monthly family income up to Rs. 50000 was noted in 48 (48%) while more than 50000 rupees was noted in 52 
(52 %) of our study cases. Mean body mass index of our study cases was 23.62 ± 2.18 kg/m
2 
and BMI more than 
25 kg/m
2
 was noted in 18 (18 %) of our study cases. Of these 100 study cases, 78 (78%) had PASI less than 10 
while 22 (22%) had PASI equal /more than 10. Mean MPV was 8.63 ±  0.67 fL (with minimum MPV was 7.8 fL 
while maximum was 9.9 fL).  
 
DISCUSSION; 
Psoriasis is a chronic inflammatory disease observed at a rate of 0.91–8.5% in the adult population 
12, 13
. It is an 
ongoing progressive disease accompanied by periods of attacks and remissions, which is caused by 
immunologically mediated mechanisms 
14
. Psoriasis is related to ulcerative colitis, gastrointestinal disorders such 
as Crohn’s disease and in the group of rheumatic diseases, such as rheumatoid arthritis and ankylosing 
spondylitis. Psoriasis is defined as an immune-mediated inflammatory disease (IMID) 15, 16. 
Our study comprised of a total of 100 patients meeting inclusion criteria of our study. Of these 100 study cases, 
66 (66%) were male patients while 34 (34 %) were female patients. A study conducted by Kilic et al 
17 
has also 
reported 54 % male gender predominance which is close to our study results. A study conducted by Kim et al 
18 
from Korea has reported 64.77 % male gender predominance in patients with psoriasis vulgaris which is close to 
our study results.  
Mean age of our study cases was 39.98 ± 9.66 years (with minimum age of our study cases was 26 years while 
maximum age was 60 years). Mean age of the male patients was noted to be 41.77 ± 10.82 years while that 
female patients was 36.50 ± 5.50 years (p=0.009). Our study results have indicated that majority of our study 
cases i.e. 60 (60%) were aged up to 40 years. A study conducted by Kilic et al 
17 
has also reported 37.66 ± 14.63 
years mean of the patients with psoriasis vulgaris which is in compliance with our study results. A study 
conducted by Kim et al 
18 
from Korea has reported 39.82 ± 15.16 years mean age of the patients with psoriasis 
vulgaris which is close to our study results.  
Of these 100 study cases, 41 (41 %) belonged to rural areas and 59 (59 %) belonged to urban areas. Monthly 
family income up to Rs. 50000 was noted in 48 (48%) while more than 50000 rupees was noted in 52 (52 %) of 
our study cases.  Mean body mass index of our study cases was 23.62 ± 2.18 kg/m
2 
and BMI more than 25 kg/m
2
 
was noted in 18 (18 %) of our study cases.  
Of these 100 study cases, 78 (78%) had PASI less than 10 while 22 (22%) had PASI equal /more than 10. Mean 
MPV was 8.63 ± 0.67 fL (with minimum MPV was 7.8 fL while maximum was 9.9 fL. A study conducted by 
Kilic et al 
17 
has also reported 8.79 ± 0.86 fL mean MPV among patients with psoriasis vulgaris which is similar 
to our study results. A study conducted by Kim et al 18 from Korea has reported 9.92 ± 0.73 fL mean MPV 
among patients with psoriasis vulgaris which is in compliance with our study results. In our study mean MPV 
was significantly elevated in patients with PASI equal or more than 10 (8.29 ± 0.23 fL and 9.83 ± 0.07 fL, p = 
0.000, respectively). Similar observations have been made by Kim et al 
18 
who reported elevated MPV with 
increasing PASI (p=0.006). These findings are in compliance with our study results. A study conducted by 
Canpolat et al 
 19 
also reported 8.7 ± 0.9 fL mean MPV among patients with psoriasis which is close to our study 
results.  
 
CONCLUSION; 
Mean platelet volume (MPV) was elevated among patients having psoriasis vulgaris and was significantly 
increased in patients with PASI ≥ 10 or disease severity. MPV is a good marker for disease severity of psoriasis 
vulgaris. MPV was significantly associated with gender, age, socioeconomic status, BMI and disease severity. 
All the clinicians treating such patients should regularly monitor MPV levels for early diagnosis of severity of 
the disease for better clinical outcomes.  
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